Allergan Plc's ability to collect accounts receivable sequentially worsen to 5.32, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Allergan Plc's Accounts Receivable average collection period in the Mar 31 2020 quarter, has increased to 69 days, from 68 days, in the Dec 31 2019 quarter.

If we take a look into Healthcare sector 337 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 2660.

What is Receivable Turnover Ratio?
What is Allergan Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AGN Receivables Turnover Ratio	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter
Y / Y Receivable Change	2.54 %	11.3 %	6.56 %	11.79 %	3.49 %
Y / Y Revenue Change	0.2 %	6.65 %	3.56 %	-0.83 %	-2.04 %
Receivable Turnover Ratio (TTM)	5.32	5.35	5.41	5.45	5.62
AGN's Total Ranking	# 2660	# 2660	# 3099	# 3099	# 2659
Accounts Receivable average collection period days	69	68	67	67	65
Seq. Receivable Change	-12.27 %	5.98 %	-2.4 %	13 %	-4.77 %
Seq. Revenue Change	-17.16 %	7.41 %	-0.96 %	13.71 %	-11.83 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 120
Healthcare Sector	# 338
Overall Market	# 2660

Receivable Turnover Ratio Statistics
High	Average	Low
12.14	7.47	5.32
(Dec. 30, 2013)		(Mar 31 2020)

AGN Company Profile • Back to AGN Efficiency Comparisons • Compare AGN Receivables Turnover Ratio to its Competitors

Financial Statements
Allergan Plc's Accounts Receivable	$ 2,801 Millions	Visit AGN's Balance sheet
Allergan Plc's Sales TTM	$ 16,096 Millions	Visit AGN's Income Statement
Sources of AGN's Revenues		Visit AGN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AGN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AGN's Growth Rates	AGN's Roa	AGN's Inventory Turnover Ratio	AGN's Dividend Comparisons
AGN's Profitability Ratios	AGN's Roi	AGN's Asset Turnover Ratio	AGN's Dividend Growth
AGN's Valuation Ratios	AGN's Roe	AGN's Financial Strength Ratios	AGN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2020	Receivable at quarter ending Mar 31 2020
Cv Sciences Inc	15.67	$ 47.055 Millions	$ 3.004 Millions
Vbi Vaccines Inc	15.56	$ 2.276 Millions	$ 0.146 Millions
Ibio inc	15.27	$ 1.313 Millions	$ 0.086 Millions
Otonomy Inc	15.25	$ 0.568 Millions	$ 0.037 Millions
Corcept Therapeutics Inc	15.09	$ 334.904 Millions	$ 22.198 Millions
Chemed Corporation	15.06	$ 1,992.319 Millions	$ 132.279 Millions
Diversicare Healthcare Services Inc	14.96	$ 460.654 Millions	$ 30.790 Millions
Sanuwave Health Inc	14.61	$ 1.499 Millions	$ 0.103 Millions
Rafael Holdings Inc	14.60	$ 5.072 Millions	$ 0.348 Millions
Agenus Inc	14.54	$ 85.285 Millions	$ 5.867 Millions
Tivity Health Inc	14.38	$ 1,254.718 Millions	$ 87.228 Millions
The Pennant Group Inc	14.30	$ 352.473 Millions	$ 24.649 Millions
Momenta Pharmaceuticals inc	14.30	$ 28.644 Millions	$ 2.003 Millions
Emmaus Life Sciences Inc	14.21	$ 29.246 Millions	$ 2.058 Millions
Ontrak Inc	14.20	$ 40.622 Millions	$ 2.861 Millions
Generex Biotechnology Corp	14.16	$ 2.027 Millions	$ 0.143 Millions
Mannkind Corporation	14.04	$ 61.825 Millions	$ 4.403 Millions
Imac Holdings Inc	13.76	$ 15.678 Millions	$ 1.140 Millions
Mimedx Group Inc	13.75	$ 294.436 Millions	$ 21.412 Millions
Personalis Inc	13.57	$ 70.293 Millions	$ 5.180 Millions
Musclepharm Corporation	13.56	$ 77.123 Millions	$ 5.688 Millions
Myomo Inc	13.51	$ 4.016 Millions	$ 0.297 Millions
Sanara Medtech Inc	12.98	$ 15.771 Millions	$ 1.215 Millions
Kadmon holdings inc	12.97	$ 11.589 Millions	$ 0.894 Millions
Rockwell Medical inc	12.77	$ 61.600 Millions	$ 4.825 Millions
1life Healthcare Inc	12.64	$ 292.004 Millions	$ 23.100 Millions
Catalyst Pharmaceuticals Inc	12.55	$ 118.994 Millions	$ 9.482 Millions
Integrated Biopharma Inc	12.47	$ 52.818 Millions	$ 4.236 Millions
Dariohealth Corp	12.45	$ 6.984 Millions	$ 0.561 Millions
Adapthealth Corp	12.20	$ 601.585 Millions	$ 49.317 Millions

Date modified: 2026-09-08T15:09:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.